RecruitingPhase 2NCT06038630

129Xe MRI Cardiopulmonary

Studying Chronic thromboembolic pulmonary hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Bastiaan Driehuys
Principal Investigator
Joseph Mammarappallil, MD
Duke University
Intervention
Hyperpolarized Xe129(drug)
Enrollment
125 enrolled
Eligibility
18 years · All sexes
Timeline
20242028

Study locations (1)

Collaborators

National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06038630 on ClinicalTrials.gov

Other trials for Chronic thromboembolic pulmonary hypertension

Additional recruiting or active studies for the same condition.

See all trials for Chronic thromboembolic pulmonary hypertension

← Back to all trials